Taken together, the inhibition of VEGFR1 signaling might contribute to the beneficial effects of anti-VEGF-A/anti-PlGF in AMD, as it is likely to help control the pathogenic inflammation. The gene discussed is PGF; the disease is age-related macular degeneration.